Analyzing Clinical Trial Experiences of Prostate Cancer Patients
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT05411354
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.
Key Dates
- Start date
- Sep 30, 2024
- Status verified
- Dec 2023
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 400 participants (estimated)
Primary Outcome Measure
Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill415-287-9919
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 | - |
Find similar trials in San Francisco, CA
Related Studies
- Active Surveillance for Cancer of the Prostate (ASCaP)Recruiting · Jonsson Comprehensive Cancer Center · Los Angeles, California
- SBRT Boost for Unfavorable Prostate Cancer'Recruiting · MemorialCare Health System · Fountain Valley, California
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerEARLY_PHASE1 · Recruiting · Ivan de Kouchkovsky, MD · San Francisco, California
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska